Trimetazidine
Showing 1 - 25 of 32
Non-Alcoholic Fatty Liver Disease Trial in Giza (conventional treatment, Furosemide or other alternatives , Niaspan or other
Recruiting
- Non-Alcoholic Fatty Liver Disease
- conventional treatment
- +2 more
-
Giza, October 6, EgyptMaha Youssif Fekry
Nov 18, 2023
Diabetes, Type 2, Diabetic Cardiomyopathies Trial in Cairo (Trimetazidine DiHCl, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Diabetic Cardiomyopathies
- Trimetazidine Dihydrochloride
- Placebo
-
Cairo, EgyptAinshams university hospitals
Sep 26, 2022
Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology Trial in Aarhus N (Trimetazidine, Placebo)
Recruiting
- Transthyretin Amyloid Cardiopathy
- Mitochondrial Pathology
- Trimetazidine
- Placebo
-
Aarhus N, Danmark, DenmarkAarhus University Hospital, Department of Cardiology
Jan 26, 2023
AKI - Acute Kidney Injury Trial in Bani Suwayf (Trimetazidine 35 mg, Allopurinol 300 MG, Normal saline)
Not yet recruiting
- AKI - Acute Kidney Injury
- Trimetazidine 35 mg
- +2 more
-
Banī Suwayf, Beni-Suef, EgyptFaculty of Pharmacy, Beni-Suef University
Sep 13, 2022
Diabetic Nephropathies Trial (Trimetazidine)
Not yet recruiting
- Diabetic Nephropathies
- Trimetazidine
- (no location specified)
Nov 24, 2021
Objective Confirmation of th? Anti-ischemic Effectiveness of
Recruiting
- Coronary Artery Disease
- speckle tracking mode of the stress ECHO test with dobutamine
-
Kemerovo, Russian Federation
- +1 more
Apr 8, 2022
Cardiotoxicity Trial (Trimetazidine)
Not yet recruiting
- Cardiotoxicity
- Trimetazidine
- (no location specified)
Jun 17, 2021
Amyotrophic Lateral Sclerosis, Motor Neuron Disease Trial in Brisbane, Utrecht, London (Trimetazidine DiHCl)
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
- Trimetazidine Dihydrochloride
-
Brisbane, Queensland, Australia
- +2 more
Aug 23, 2021
Aluminum Phosphide Poisoning Trial (standard treatment, trimetazidine HCl "metacardia" ® 20 mg tablet)
Not yet recruiting
- Aluminum Phosphide Poisoning
- standard treatment
- trimetazidine hydrochloride "metacardia" ® 20 mg tablet
- (no location specified)
Jan 8, 2021
Acute Respiratory Distress Syndrome, Covid19, Myocardial Injury Trial in Sao Paulo (Trimetazidine)
Unknown status
- Acute Respiratory Distress Syndrome
- +2 more
- Trimetazidine
-
Sao Paulo, SP, BrazilHeart Institute (InCor-HCFMUSP)
Feb 18, 2021
Acute-On-Chronic Liver Failure Trial in Worldwide (Trimetazidine)
Suspended
- Acute-On-Chronic Liver Failure
- Trimetazidine
-
Graz, Austria
- +23 more
Mar 2, 2021
Percutaneous Coronary Intervention Trial in China (Yangxinshi, Trimetazidine, Yangxinshi mimic)
Recruiting
- Percutaneous Coronary Intervention
- Yangxinshi
- +3 more
-
Hefei, Anhui, China
- +14 more
Oct 15, 2020
Platelet Dysfunction Due to Drugs Trial in Saint Augustine (Trimetazidine)
Completed
- Platelet Dysfunction Due to Drugs
- Trimetazidine
-
Saint Augustine, North, Trinidad and TobagoThe University of the West Indies
Nov 28, 2019
Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine Trial (Wen Xin granule, Clopidogrel Hydrogen Sulfate 75 MG Oral
Not yet recruiting
- Coronary Heart Disease
- +2 more
- Wen Xin granule
- +8 more
- (no location specified)
Jan 21, 2021
Precapillary Pulmonary Hypertension Trial in Jakarta (Trimetazidine, Placebo oral capsule)
Completed
- Precapillary Pulmonary Hypertension
- Trimetazidine
- Placebo oral capsule
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Hospital
Sep 11, 2019
Coronary Artery Trial in Seoul (Pravastatin 20mg/day for 12 months after randomization, Atorvastatin 40 mg and trimetazidine MR
Completed
- Coronary Artery
- Pravastatin 20mg/day for 12 months after randomization
- Atorvastatin 40 mg and trimetazidine MR 70 mg/day for 12 months after randomization
-
Seoul, Korea, Republic ofSeverance Hospital
Mar 27, 2019
Diabetes, Angina, Unstable Trial in São Paulo (trimetazidine, Placebo Oral Tablet)
Unknown status
- Diabetes Mellitus
- Angina, Unstable
- trimetazidine
- Placebo Oral Tablet
-
São Paulo, BrazilInstituto do Coração - HMFMUSP
Oct 22, 2018
Coronary Heart Disease, Diastolic Dysfunction Trial in Beijing (Trimetazidine)
Unknown status
- Coronary Heart Disease
- Diastolic Dysfunction
- Trimetazidine
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences, National Ce
Mar 21, 2019
Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease) Who Have Coronary Microvascular Dysfunction Trial
Unknown status
- Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease) Who Have Coronary Microvascular Dysfunction
- Trimetazidine
- (no location specified)
Oct 24, 2018
NSCLC, Cardiovascular Complication Trial in Guangzhou (Multiple cardiovascular drugs related to "Golden Triangle")
Recruiting
- Non-small Cell Lung Cancer
- Cardiovascular Complication
- Multiple cardiovascular drugs related to "Golden Triangle"
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Jul 24, 2021
Chronic Heart Failure Trial in Dalian (YanXinShi pills, YanXinShi pills, Trimetazidine pills)
Unknown status
- Chronic Heart Failure
- YanXinShi placebo pills
- +3 more
-
Dalian, Liaoning, ChinaDept. of Cardiology, Affiliated Zhongshan hospital of Dalian Uni
Nov 26, 2017
HCC Trial in Zhengzhou (Basic drugs therapy of HCC by TACE, Arginine HCl, Trimetazidine HCl)
Unknown status
- HCC
- Basic drugs therapy of HCC by TACE
- +2 more
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Sep 14, 2017
HCC Trial in Zhengzhou (Basic drugs therapy of HCC, Arginine HCl, Trimetazidine HCl)
Unknown status
- HCC
- Basic drugs therapy of HCC
- +2 more
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Sep 9, 2017
Coronary Artery Disease(CAD) Trial (Shexiang Baoxin pill, SBP , Aspirin Enteric-coated Tablets)
Unknown status
- Coronary Artery Disease(CAD)
- Shexiang Baoxin pill
- +7 more
- (no location specified)
Mar 30, 2017
Coronary Artery Disease(CAD) Trial (Danlou Tablet, DanLou Tablet , Aspirin Enteric-coated Tablets)
Unknown status
- Coronary Artery Disease(CAD)
- Danlou Tablet
- +7 more
- (no location specified)
Mar 30, 2017